Today is International Women's Day, a day set aside to explore and celebrate the contributions and achievements of women while also bringing visibility to issues of gender disparity that could still use improvement. In today's post, we will look at gender disparities in the medical field, with an emphasis on fields in infection control.
Despite recent controversies about the quality of care in VA hospitals, the network of 163 acute care hospitals and over 1,000 outpatient clinics is actually a national leader when it comes to many treatments and outcomes. Due to incidents of patient harm stemming from, among other issues, prolonged wait times for procedures, the VA instituted a rigorous self-evaluation as well as evaluation from outside experts. The results pointed to changes needed for improvement, but also revealed successes and positive outcomes where the VA exceeds private sector health care. One of those areas is in infection control, and today's post will explore how the VA achieved a leadership role in this area.
This week, the EOSCU Team had the honor of presenting at the Centers for Disease Control and Prevention (CDC) campus outside of Atlanta, GA. During our meeting with the Division of Healthcare Quality Promotion, we were able to share information about our product as well as data from our recent clinical study. This meeting was anything but one-sided, however - the experts at the CDC were able to identify directions and partnerships we should explore in the future. This visit prompted us to present this post about the CDC, and what it does for our nation and the world on a daily basis.
The term "white paper" comes to us from a 100-year-old practice of government reportingin the UK. When government agencies provided data to Parliament to help them make decisions, they would offer three different types: Very long, comprehensive documents with a blue cover, open-ended reports with a green cover, and short, focused reports on a single topic with white covers. This last type, the concise document with information to solve a problem, came to be the formula for what is now known in many industries as a "white paper." Today, white papers are produced for sales purposes by for-profit companies, making them a marketing tool that can often be confused with a neutral scientific paper. While both publications have their purpose, it is important for the consumer to know how they differ. Today we will compare these two documents in order to help our readers see beyond the surface similarities and become aware of the important differences.
We at the Health.Care. blog value science and scientists. We trust the scientific method to propose new ideas, and then test, defend, critique, replicate and establish those ideas as quality research. We also recognize the value in stepping back and returning to the literature, reevaluating a premise, and even scrapping a project in order to begin again.
Today we celebrate the birth of an scientist known as the Father of Microbiology for his role in the use of lenses to observe the microscopic world. Optics and lens-making developed quickly in 16-17th century Europe, allowing research to expand to the universe. But just as lenses could sharpen light from far away, allowing Galileo to see Jupiter's moons, it could also magnify objects right in the laboratory. The microscope was invented by several lens makers at around the same time in the late 1500s and the technology spread throughout Europe. In the 1660s, however, the use of microscopes for intense research grew explosively. Discovery after discovery began to lay the groundwork for modern biology.
The US government is one of the largest funders of scientific study in the world. The National Institutes of Science alone funds more medical research than any other source globally. How does the federal government allocate funds to study science? Who decides what goes where? And what role does the President play in this funding? Today we will delve into the complicated process of funding allocations, and how that money funds science.
As we enter the heated month before Election Day, we are going to take an opportunity to explore the relationship between science and our government over the course of a few blog posts. We’ll explore a few key questions: How important was science to the Founding Fathers who penned the documents that still guide us today? How have Presidents interacted with the advancement of science since the birth of our nation? Just how involved is our current government in science, and finally, how do the two major party candidates differ with relation to science? Stay with us over the next few weeks to find out!
In scientific research, we test interventions to a problem and then measure the result: Did a medication improve patient outcomes? Did a training program lead to improved hand hygiene? Did copper-impregnated materials reduce the number of healthcare-associated infections? Simple before-and-after measurement is not enough when it comes to generating strong evidence. While the patients, the hand hygiene, and the infection rates may improve, it is vital to demonstrate that the intervention being studied was the cause of that improvement. How does a researcher demonstrate strong evidence? This post will explore the statistical representation of strength of evidence: The p value.
Less than 100 years ago today, American women were given the right to vote. For less than half of that time, August 26th has been recognized as Women’s Equality Day, a day to celebrate the struggles and successes of this movement to allow women to have a say in elections, and a voice in society as a whole. This struggle for a say and a voice continues, and while there has been tremendous progress, this struggle is quite visible in the world of science. Today’s post will celebrate the achievements of female scientists, while also discussing the two major obstacles women in science face, even today.